With a $93 million settlement, Pfizer can wash its hands of more than a decade's worth of antitrust litigation over the once-lucrative cholesterol med Lipitor. For years, Pfizer and Sun Pharma’s ...

Feb 14 (Reuters) - Pfizer (PFE.N), opens new tab has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories ...

Pharmaceutical giant Pfizer has agreed to pay $35 million to settle allegations that it unlawfully hindered the sale of Lipitor, a drug prescribed to lower cholesterol, resulting in buyers paying more ...

Dr. Reddy's Laboratories is in the midst of a large recall of its generic version of Lipitor—and that's not the only product it's yanking from the U.S. market. Dr. Reddy’s Princeton, New Jersey, ...

Pfizer Inc PFE has agreed to pay $93 million to settle an antitrust lawsuit related to its cholesterol drug Lipitor. What Happened: The lawsuit, filed by wholesale drug distributors, accused Pfizer of ...

In turn, this reduces the risk of atherosclerosis complications like heart attack, stroke, chest pain and aneurysms. Lipitor can also raise the levels of HDL cholesterol good cholesterol in your blood ...

Pfizer has invited an unspecified number of agencies to pitch for the consumer business on its cholesterol- lowering blockbuster Lipitor, the company confirmed today. “We’ve invited a range of leading ...

Jarvik says his role in Lipitor ad currently being investigated is educational. Jan. 16, 2008 — -- Robert Jarvik, the inventor of the artificial heart, is at the center of a congressional ...

Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease NEW YORK, March 7 -- Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved ...

REUTERS - As cholesterol fighter Lipitor goes generic, its maker Pfizer Inc is hoping to hold onto perhaps a third of the 3 million Americans who take the biggest-selling drug of all time. Lipitor, ...

Drug prices almost always fall after a manufacturer’s patent expires and generics hit the market. But with its blockbuster cholesterol-fighting drug Lipitor going off-patent this week, drug maker ...

(Reuters) - Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales of less ...